AUTOVAC

Welcome to the Brand page for “AUTOVAC”, which is offered here for In the statement, column 2, line 12 after the word vivo preclinical testing of potential drugs; in vitro and in vivo should be inserted.;pharmaceutical preparations for use in the treatment of neoplastic disorders, inflammatory disorders, infectious diseases, traumatic disorders, metabolic disorders, hematologic respiratory disorders, vascular and cardial disorders, endocrinologic disorders, muscular disorders, skeletal and bone disorders, neurological disorders, skin and mucosal disorders, psychiatric disorders, lymphatic disorders, intestinal disorders, urologic disorders, and reproductive disorders; medical diagnostic reagents; diagnostic preparations for clinical or medical laboratory use; vaccines, including therapeutic vaccines, subcomponent vaccines, polypeptide vaccines, live vaccines, viral vaccines, nucleid acid vaccines and dna-vaccines, vaccine recipients, vaccine carriers, vaccines adjuvants; non-pathogenic microorganisms and vira for vaccine use, polypeptides, protein and nucleic acids, including dna for vaccine use;auto vac;reagents for scientific or medical research use; diagnostic preparations for scientific or research use;live animals;scientific, industrial biotechnological and biomedical research; development of therapeutic vaccines, other vaccines and pharmaceuticals for others; chemical, biochemical and molecular biological analyses; medical research in the nature of in vitro and in vivo * preclinical testing of potential drugs; in vitro and in vivo * research concerning therapeutic vaccines, other vaccines and potential drugs; medical, chemical, scientific, biotechnological, biomedical and molecular biological consultation services provided in connection with the aforementioned services; medical industrial, chemical, scientific, biotechnological, biomedical and molecular biological testing and research;.

Its status is currently believed to be active. Its class is unavailable. “AUTOVAC” is believed to be currently owned by “M & E Biotech A/S”.


Owner:
M & E BIOTECH A/S
Owner Details
Description:
In the statement, Column 2, line 12 after the word vivo PRECLINICAL TESTING OF POTENTIAL DRUGS; IN VITRO AND IN VIVO should be inserted.;PHARMACEUTICAL PREPARATIONS FOR USE IN THE TREATMENT OF NEOPLASTIC DISORDERS, INFLAMMATORY DISORDERS, INFECTIOUS DISEASES, TRAUMATIC DISORDERS, METABOLIC DISORDERS, HEMATOLOGIC RESPIRATORY DISORDERS, VASCULAR AND CARDIAL DISORDERS, ENDOCRINOLOGIC DISORDERS, MUSCULAR DISORDERS, SKELETAL AND BONE DISORDERS, NEUROLOGICAL DISORDERS, SKIN AND MUCOSAL DISORDERS, PSYCHIATRIC DISORDERS, LYMPHATIC DISORDERS, INTESTINAL DISORDERS, UROLOGIC DISORDERS, AND REPRODUCTIVE DISORDERS; MEDICAL DIAGNOSTIC REAGENTS; DIAGNOSTIC PREPARATIONS FOR CLINICAL OR MEDICAL LABORATORY USE; VACCINES, INCLUDING THERAPEUTIC VACCINES, SUBCOMPONENT VACCINES, POLYPEPTIDE VACCINES, LIVE VACCINES, VIRAL VACCINES, NUCLEID ACID VACCINES AND DNA-VACCINES, VACCINE RECIPIENTS, VACCINE CARRIERS, VACCINES ADJUVANTS; NON-PATHOGENIC MICROORGANISMS AND VIRA FOR VACCINE USE, POLYPEPTIDES, PROTEIN AND NUCLEIC ACIDS, INCLUDING DNA FOR VACCINE USE;AUTO VAC;REAGENTS FOR SCIENTIFIC OR MEDICAL RESEARCH USE; DIAGNOSTIC PREPARATIONS FOR SCIENTIFIC OR RESEARCH USE;LIVE ANIMALS;SCIENTIFIC, INDUSTRIAL BIOTECHNOLOGICAL AND BIOMEDICAL RESEARCH; DEVELOPMENT OF THERAPEUTIC VACCINES, OTHER VACCINES AND PHARMACEUTICALS FOR OTHERS; CHEMICAL, BIOCHEMICAL AND MOLECULAR BIOLOGICAL ANALYSES; MEDICAL RESEARCH IN THE NATURE OF IN VITRO AND IN VIVO * PRECLINICAL TESTING OF POTENTIAL DRUGS; IN VITRO AND IN VIVO * RESEARCH CONCERNING THERAPEUTIC VACCINES, OTHER VACCINES AND POTENTIAL DRUGS; MEDICAL, CHEMICAL, SCIENTIFIC, BIOTECHNOLOGICAL, BIOMEDICAL AND MOLECULAR BIOLOGICAL CONSULTATION SERVICES PROVIDED IN CONNECTION WITH THE AFOREMENTIONED SERVICES; MEDICAL INDUSTRIAL, CHEMICAL, SCIENTIFIC, BIOTECHNOLOGICAL, BIOMEDICAL AND MOLECULAR BIOLOGICAL TESTING AND RESEARCH;
Categories: STATEMENT